Apr 22 |
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
|
Apr 9 |
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
Apr 6 |
Shareholders in Profound Medical (TSE:PRN) are in the red if they invested three years ago
|
Mar 10 |
Profound Medical Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 8 |
Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Profound Medical GAAP EPS of $0.42 beats by $0.74, revenue of $2M beats by $0.06M
|
Mar 7 |
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|
Mar 4 |
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
|
Feb 27 |
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
|